Dutch Breast Cancer Research Group

The BOOG Study Group (Borstkanker Onderzoek Groep) is the primary clinical research organization in the Netherlands dedicated to breast cancer trials. Founded in 2000 as a non-profit foundation, the group coordinates multi-center clinical studies to improve treatment outcomes and quality of life for patients. BOOG collaborates with nearly all Dutch hospitals and maintains strong international partnerships with organizations like the Breast International Group (BIG). Their research portfolio includes significant phase 2 and phase 3 trials investigating endocrine therapies, targeted biologics, and chemotherapy. By centralizing trial management and biobanking, BOOG facilitates high-impact academic research and industry-sponsored studies. The organization plays a critical role in establishing national treatment guidelines and advancing personalized medicine in oncology.